New Appointments To The OPTIMA Management Board

The Optima group has completed the generational change in its management: The group with around 3,150 employees at more than 20 locations in Germany and abroad, will be led by Stefan König, Hans Bühler, Marco Beyl and Johannes-Thomas Grobe.

Building a stable management team for the coming years: This was an important task for the Optima Group this year. Two positions had to be filled for reasons of age. After a structured one-year handover process, this has now been successfully completed. Marco Beyl and Johannes-Thomas Grobe have taken over the responsibilities of their predecessors. They join CEO Stefan König and Managing Partner Hans Bühler on the Management Board.

As CFO, Marco Beyl is responsible for all areas of finance, administration and materials management. The 47-year-old industrial engineer has extensive management experience in the project business as well as international expertise in medium-sized and large companies.

Johannes-Thomas Grobe heads the successful Pharmaceuticals Division as CEO Pharma. The 58-year-old Doctor of Engineering has many years of experience in mechanical and plant engineering as well as in drive and control technology. In his previous positions, he was responsible for major projects and worked in management in Germany and abroad.

Shareholder Hans Bühler and CEO Dr Stefan König complete the management team. König is responsible for the overall development of the group and the business units Consumer, Nonwovens, Life Science and New Energy. Bühler is focusing on future issues, strategic decisions and the shareholder base.

The company can therefore count on proven expertise for its further development. The foundation of the company's philosophy, based on the mission statement 'We care for people', remains unchanged and provides a clear direction for strategic decisions. “Optima stands on solid economic foundations that we want to maintain and strengthen,” said Marco Beyl.

The family-owned company is focused on being a global solutions provider in key markets and is pursuing ambitious growth targets. The enduring values, that have characterized more than a century of success, will continue to create an attractive working environment. “Together with our employees, we will implement our vision in the best possible way,” said Stefan König.

 “We see further significant growth opportunities, particularly in the pharmaceutical market, which we will exploit. We offer our employees jobs with good prospects for the future,” explained Johannes-Thomas Grobe.

The previous CFO, Jan Glass, and Gerhard Breu, former Chairman of Optima Pharma, will continue to support the company in an advisory capacity. “They deserve our sincere thanks and respect for their contribution to the successful development of the company,” emphasized Hans Bühler.